The impact of botulinum toxin on the health, physical condition, and mental well-being of individuals suffering from chronic migraines

Abstract

Introduction and purpose: Migraines are one of the most common neurological conditions in the world. They are characterized by recurring, intense headaches, often on one side of the head, which may be accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. Migraines affect overall well-being and are an indicator of health, as well as potentially causing difficulties in normal functioning. One of the most effective methods of treating migraines in recent times has become botulinum toxin. This literature review will discuss how botulinum toxin affects the body and the course of treatment for chronic migraines.

Material and methods: The literature was conducted using "Pub Med" and "Google Scholar"

databases with the keywords „botulinum toxin”, „botox”, „migraine”, „botulinum toxin type A”.

Brief description of the state of knowledge: Treatment of chronic migraines with type A botulinum toxin preparations was a breakthrough discovery. This medication demonstrates high effectiveness and better tolerance compared to other preparations used in the treatment of chronic migraines.

Results and conclusions: Type A botulinum toxin has emerged as a versatile therapeutic tool with approved indications for treating chronic migraines and various other medical conditions. Despite its widespread application, gaps in research persist, particularly concerning its use during pregnancy, lactation, and among individuals under 18 years old. Further comprehensive studies in these demographics hold the potential to revolutionize chronic migraine treatment approaches. The administration method of botulinum toxin, exemplified by the Botox (Allergan) preparation, is meticulously defined and substantiated by extensive research validating its efficacy over the years.